MetLife Investment Management’s Tricida, Inc. Common Stock TCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,650
Closed -$185K 2855
2022
Q3
$185K Hold
17,650
﹤0.01% 2348
2022
Q2
$171K Buy
+17,650
New +$168K ﹤0.01% 2425
2020
Q4
Sell
-12,989
Closed -$118K 2327
2020
Q3
$118K Hold
12,989
﹤0.01% 2142
2020
Q2
$357K Buy
12,989
+2,728
+27% +$74.3K ﹤0.01% 1562
2020
Q1
$226K Hold
10,261
﹤0.01% 1634
2019
Q4
$387K Hold
10,261
﹤0.01% 1600
2019
Q3
$317K Hold
10,261
﹤0.01% 1678
2019
Q2
$405K Buy
10,261
+1,457
+17% +$51.2K ﹤0.01% 1606
2019
Q1
$340K Buy
8,804
+3,587
+69% +$83.6K ﹤0.01% 1681
2018
Q4
$123K Sell
5,217
-2,993
-36% -$86K ﹤0.01% 2183
2018
Q3
$251K Buy
+8,210
New +$241K ﹤0.01% 1956

Other funds holding TCDA

MetLife Investment Management's TCDA Position: Q4 2022 in Review

MetLife Investment Management sold out of Tricida, Inc. Common Stock (TCDA) in Q4 2022, closing a stake of 17,650 shares — an estimated $185K sold.

MetLife Investment Management first reported a position in TCDA in Q3 2018 and held it in 11 quarters. The position peaked at $405K in Q2 2019. 70 funds tracked by Wall St. Rank hold TCDA as of Q4 2022.

  • MetLife Investment Management reported no remaining Tricida, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • MetLife Investment Management sold 17,650 Tricida, Inc. Common Stock shares in Q4 2022, an estimated $185K.
  • MetLife Investment Management first reported a position in Tricida, Inc. Common Stock in Q3 2018 and held it in 11 quarters.
  • MetLife Investment Management's Tricida, Inc. Common Stock position peaked at $405K in Q2 2019.
  • 70 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q4 2022.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.